Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDMO | Common Stock, $0.001 par value | Options Exercise | $23.4K | +5K | +14.2% | $4.67 | 40.2K | Mar 1, 2022 | Direct | F1 |
transaction | CDMO | Common Stock, $0.001 par value | Sale | -$99.3K | -5K | -12.44% | $19.86 | 35.2K | Mar 1, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDMO | Stock Option (right to buy) | Options Exercise | $0 | -5K | -2.09% | $0.00 | 234K | Mar 1, 2022 | Common Stock | 5K | $4.67 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 15, 2021. |
F2 | Represents a weighted average sales price per share. These shares were sold at prices ranging from $19.49 to $20.63. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F3 | Stock option granted to the reporting person on November 27, 2017 vested monthly over a three (3) year period and was fully vested as of November 27, 2020. |